Exicure, Inc. (XCUR) — 10-K Filings
All 10-K filings from Exicure, Inc.. Browse 3 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (3)
-
Exicure Pivots to Acquisitions, Korean Biotech After IP Sale
— Mar 25, 2026 Risk: high
EXICURE, INC. (XCUR) reported a significant strategic shift in 2025, moving away from its historical biotechnology focus. The company halted all research and de -
Exicure, Inc. Files 2024 Annual Report
— Mar 18, 2025 Risk: medium
Exicure, Inc. filed its 2024 10-K on March 18, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, previously k -
Exicure, Inc. Files 2023 Annual Report
— Jun 6, 2024 Risk: medium
Exicure, Inc. filed its 2023 10-K on June 6, 2024, reporting its financial performance for the fiscal year ending December 31, 2023. The company, previously kno
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX